Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of Tongluo Kaibi Tablet for rheumatoid arthritis and knee osteoarthritis
ChiCTR2200065109Phase 4Completed
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tongluo kaibi in rheumatoid arthritis (RA) and knee osteoarthritis (OA), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Visual analogue pain score and Health Assessment Questionnaire. Started May 2021; status: completed.
02
Drugs
tongluo kaibi
03
Conditions
rheumatoid arthritis (RA)knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2200065109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065109.